Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01923350 · ClinicalTrials.gov registry record · NA
Avoiding Diabetes After Pregnancy Trial
A NA study of Weight Reduction, sponsored by Social & Scientific Systems.
- Completed
- Registry status
- NA
- Development phase
- 140
- Enrollment target
- 1
- Study location
NCT01923350 is a NA study of Weight Reduction that has completed, run by Social & Scientific Systems. The registered enrollment target is 140 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01923350, a NA study of Weight Reduction, has completed, sponsored by Social & Scientific Systems.
- COMPLETED
- Registry status
- NA
- Development phase
- 140 participants
- Enrollment target
- 1
- Study location
Study Summary
The Avoiding Diabetes After Pregnancy Trial (ADAPT) study was designed to test the effectiveness of interventions that potentially increase the adoption of Diabetes Prevention Program (DPP) elements by women who had a pregnancy with gestational diabetes mellitus (GDM). The study was conducted as an integrated trial with two separate arms: one to facilitate weight reduction and the other to increase diabetes testing. There were two hypotheses: 1. Women in the testing intervention will be more likely to have received a diabetes test within the 6 months post-intervention than women in the control group. 2. Women in the weight reduction intervention will have lost more weight at the 6-month and 9-month follow-up than women in the control group. The primary study aim was to determine the efficacy of a system of interactive technology-based supports to prompt women with a history of gestational diabetes to take steps to prevent diabetes. The secondary aims were focused on women's engagement: * To evaluate the impact of the weight reduction intervention in terms of participant engagement with the interactive technology-based supports. * To evaluate changes in the women's perception of their personal diabetes risk following after exposure to information about diabetes risk following a pregnancy with GDM. * To identify the determinants and motivators of and barriers to diabetes testing in the 6- to 12-week postpartum period and thereafter, using the Health Belief model to guide the study. There was an additional secondary aim involving metformin: * To evaluate the impact of the diabetes risk reduction intervention in terms of women seeking out their physician's advice on metformin treatment and receiving a metformin prescription, if appropriate.
Conditions Studied
Interventions
- BEHAVIORAL Weight Reduction Intervention
- BEHAVIORAL Weight Reduction Control Arm
- BEHAVIORAL Tested for diabetes
- BEHAVIORAL Not tested for diabetes
Study Locations (1)
Maryland
- Social & Scientific Systems Inc. - Silver Spring
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 140 participants |
| Start Date | 2011-12 |
| Est. Completion | 2013-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01923350
The ClinicalTrials.gov registry entry for NCT01923350 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 140 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Social & Scientific Systems, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Weight Reduction appearing as the primary indexed condition, and to 4 interventions - of which Weight Reduction Intervention is the first listed.
NCT01923350 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT01923350 about?
NCT01923350 is a clinical study titled "Avoiding Diabetes After Pregnancy Trial". The Avoiding Diabetes After Pregnancy Trial (ADAPT) study was designed to test the effectiveness of interventions that potentially increase the adoption of Diabetes Prevention Program (DPP) elements by women who had a pregnancy with gestational diabetes mellitus (GDM). The study was conducted as an...
What is the current status of trial NCT01923350?
This trial is currently completed. It is a NA study. The enrollment target is 140 participants. The study started on 2011-12. Estimated completion is 2013-03.
What conditions does trial NCT01923350 study?
This clinical trial studies the following conditions: Weight Reduction.
What interventions are being tested in trial NCT01923350?
The interventions under investigation include: Weight Reduction Intervention (BEHAVIORAL), Weight Reduction Control Arm (BEHAVIORAL), Tested for diabetes (BEHAVIORAL), Not tested for diabetes (BEHAVIORAL).
Who is sponsoring clinical trial NCT01923350?
This trial is sponsored by Social & Scientific Systems, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01923350 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.